ORINASE MET 2.0 TAB

Orinase Met 2.0 Tablets, ideal for online pharmacies, product pages, or digital medical catalogs:

Orinase Met 2.0 Tablets – Dual Oral Therapy for Type 2 Diabetes Control

Overview:
Orinase Met 2.0 Tablet is an oral anti-diabetic combination that contains:

• Glimepiride 2 mg – a sulfonylurea that stimulates insulin secretion

• Metformin 500 mg – a biguanide that reduces glucose production and improves insulin sensitivity

This fixed-dose combination is prescribed for patients with type 2 diabetes mellitus who require dual therapy to control blood glucose levels, especially when monotherapy is not enough.

Key Benefits:

• Targets both insulin resistance and insulin deficiency

• Helps in maintaining HbA1c levels

• Once or twice daily oral dosing based on medical advice

• Enhances overall glycemic control without insulin injection

• Cost-effective treatment option in diabetes management

Indications:

• Type 2 diabetes mellitus in adults

• Patients not adequately controlled with diet, exercise, or single oral agent

How It Works:

• Glimepiride boosts insulin release from pancreatic beta cells

• Metformin reduces hepatic glucose production and enhances peripheral glucose uptake

Directions for Use:

• Usually taken once or twice daily with meals

• Dose individualized by the physician based on blood sugar levels

• Should be used along with lifestyle modifications

Common Side Effects:

• Nausea, abdominal discomfort, bloating (from metformin)

• Hypoglycemia (especially if meals are skipped)

• Weight gain (mild, due to glimepiride)

• Metallic taste, headache, or dizziness (rare)

Precautions:

• Not recommended for type 1 diabetes or diabetic ketoacidosis

• Use with caution in patients with kidney, liver, or heart problems

• Regular blood sugar monitoring is essential

• Avoid excessive alcohol intake

Storage Instructions:

• Store below 30°C in a dry place

• Keep out of reach of children